Medical Device Network on MSN
Siemens Healthineers introduces Innovance D-Dimer 2.0 assay
The assay facilitates in diagnosing and monitoring hypercoagulable disorders such as disseminated intravascular coagulation.
Dublin life-science company pairs two years of researcher behaviour on its own site with PubMed publication records to ...
Please provide your email address to receive an email when new articles are posted on . The CNSide assay aims to help clinicians with early diagnosis, treatment plans for those with CNS cancers. The ...
According to the study, Amprion's α-synuclein skin SAA successfully differentiated specimens from patients with MSA versus neuronal synuclein disease (NSD) while demonstrating strong agreement with ...
Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19. Rebecca DuBois, associate professor of ...
Assays need to be specific for their research purpose, be that quantifying cellular levels of specific proteins, identification of potential new drug molecules, or quantitative measurements of levels ...
An alpha-synuclein seed amplification assay (αSyn-SAA) accurately identifies people with Parkinson's disease (PD), as well as those at risk for PD and those with early, prodromal symptoms, and ...
NATICK, Mass.--(BUSINESS WIRE)--Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer ...
Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs distant from the primary site and are often difficult to identify. A research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results